Shelley Fang
About Shelley Fang
Shelley Fang is a Bioassay Scientist with extensive experience in analytical method development and automation, currently working at both GlaxoSmithKline and Bristol-Myers Squibb.
Current Role at GlaxoSmithKline
Shelley Fang holds the position of Investigator, PMP at GlaxoSmithKline in the Greater Philadelphia Area. Her responsibilities include overseeing bioassay development and automation, phase-appropriate method validation and tech transfer, release and stability testing, and function characterization for process development. She has been with GlaxoSmithKline since January 2018.
Experience at Bristol-Myers Squibb
Shelley Fang currently works as a Bioassay Scientist at Bristol-Myers Squibb in Hopewell, NJ. In this role, she continues to leverage her extensive expertise in bioassay development and method validation, contributing to the analytical method development and automation processes.
Previous Positions at GlaxoSmithKline
Shelley Fang has held multiple roles at GlaxoSmithKline. From 2011 to 2015, she worked as a Bioassay Analyst in King of Prussia, PA, and from 2020 to 2021, she served in a CMC Project Management role as part of a secondment in Hopewell, NJ. Earlier, she was a Scientist at the Reseach Triangle Park, NC, from 2002 to 2004.
Experience at AstraZeneca
Shelley Fang's tenure at AstraZeneca spanned five years from 2005 to 2010. She worked as a Scientist at AstraZeneca R&D in Boston, contributing to various scientific projects and further honing her skills in analytical methods and bioassay development.
Educational Background
Shelley Fang received her Master's degree in Biochemistry/Signal Transduction and an Honour Bachelor's degree in Biochemistry from the University of Saskatchewan. Her academic foundation has equipped her with robust knowledge and skills essential for her roles in the pharmaceutical and biotech industries.
Expertise and Skills
Shelley Fang has broad hands-on experience in analytical method development and automation. She possesses deep expertise in regulatory and industry guidelines, particularly in the area of GMP potency assay development. Her ability to deliver complex objectives while working with cross-functional groups is well-recognized in her professional engagements.